Search
Press "Enter" to search and "ESC" to close.

Thyroid Medication Recalled Across the United States: Check If Your Treatment Is Affected

Levothyroxine recall: Authorities and the manufacturer are warning about subpotent tablets. Patients should check affected lot numbers.
2026-08-04T14:04:01-04:00
Share on FacebookShare on InstagramShare on TwitterShare on TikTokShare on YouTubeShare on WhatsApp
Suscríbete a Nuestro Boletín
Recibe por email las noticias más destacadas
Retiran medicamento para la tiroides, Levothyroxine recall
Levothyroxine Recall Across the United States: Check If Your Treatment Is Affected/Photo: Shutterstock
  • Thyroid medication recalled.
  • Check the affected lot number.
  • Consult your doctor.

Thousands of patients who use levothyroxine sodium to treat thyroid disorders could be affected by a nationwide Levothyroxine recall announced by manufacturer Major Rugby.

The company notified distributors and retailers of the recall through a letter sent earlier this month.

The recall involves several lots of tablets sold under the Major and Cardinal brands that were distributed across the United States.

Although the company said the health risk is low, it urged consumers to check their medications and return any affected products.

Levothyroxine Recall Affects Prescription Thyroid Medication

Retiran medicamento para la tiroides, Levothyroxine recall
Levothyroxine Recall Across the United States: Check If Your Treatment Is Affected-Photo: Shutterstock

Thyroid medication recalled across the United States – Photo: Shutterstock

Major Rugby has recalled 12 different strengths and presentations of levothyroxine sodium tablets.

The affected products include bottles containing 100 tablets as well as unit-dose blister packs with 10 tablets.

YOU MAY ALSO BE INTERESTED IN: Publix Expands Frozen Fruit Recall Over Possible E. coli Contamination: Here’s What You Need to Check

According to the Mayo Clinic, levothyroxine is used to treat hypothyroidism, enlargement of the thyroid gland (goiter), and a type of thyroid cancer.

According to the manufacturer’s recall notice, the affected products have been distributed nationwide since January 2025.

Manufacturer Says the Health Risk Is Low

Major Rugby stated that taking the recalled medications “is not likely to cause adverse health effects.”

However, the company recommends returning the affected tablets to the place of purchase so the recall process can be completed.

The letter sent to retailers and a report from the U.S. Food and Drug Administration (FDA) indicate that the tablets are subpotent.

This means they contain less of the active ingredient than required to provide the intended therapeutic dose during treatment.

Patients Should Review Their Treatment and Consult Their Doctor

The manufacturer also advised anyone who identifies one of the recalled products to consult their healthcare provider.

The recommendation is intended to ensure that patients receive medical guidance before making any changes to their treatment.

The recalled tablets are limited to specific lots and product presentations marketed under the Major and Cardinal brands.

Health authorities continue to share information to help consumers identify the affected products included in the Levothyroxine recall.

These Are the Lots Included in the Nationwide Levothyroxine Recall

Among the recalled products is the 25 mcg (100-tablet) presentation, lot N02212, with an expiration date of 07/2026.

Also recalled are the 50 mcg tablets (lot N02200, expiration 10/2026), the 75 mcg tablets (lots N02172, N02296, and N02288), and the 88 mcg tablets (lot N02310, expiration 01/2027).

The list also includes the 112 mcg tablets (lot N02203), the 125 mcg tablets (lot N02266), and the 150 mcg tablets (lot N02167), all in 100-tablet bottles.

In addition, unit-dose presentations of 25 mcg, 50 mcg, 125 mcg, and 150 mcg have also been recalled, including the corresponding bag and blister-pack lot numbers with the expiration dates specified by the manufacturer, according to USA Today.

National
Regresar al Inicio